ResMed has completed the previously announced acquisition of Curative Medical, a provider of non-invasive ventilation and sleep-disordered breathing medical devices and accessories.
“By joining forces with Curative Medical we expand our combined reach in the growing respiratory medical device market in China,” says Mick Farrell, ResMed CEO, in a release. “Together we will focus on improving patient quality of life while reducing the cost of care for sleep-disordered breathing and chronic obstructive pulmonary disease.”
ResMed China and Curative Medical will remain operationally independent, and Curative will continue to invest in R&D, manufacturing, marketing, and sales teams in China. Curative will keep its name, brands, and offerings tailored for the Chinese market and other global markets, and will be strategically positioned to target different customer segments than ResMed. Curative employees, including the founder and CEO, Jason Sun, will continue as employees of the combined ResMed and Curative team. Curative Medical will continue to support its products through its existing sales team and distribution network.
Financial terms of the transaction were not disclosed.
